Health & Science
CAR-T Therapy Shows First Promising Results for "Prevention" of Multiple Myeloma, Presented at AACR 2026
h Will a Phase II or higher clinical trial of Carvykti for smoldering multiple myeloma be registered and initiated by the end of 2026? 50% NO 📅 Resolution: 2026-12-31 🎯 Brier: 0.25 (h) 🔗 All Predictions What Happened ⚡ What Happened At AACR 2026, promising results were presented from an early-stage clinical trial